What is the dosage frequency for Brovana?

Brovana, which contains the active ingredient arformoterol, is a long-acting beta-agonist (LABA) indicated for the treatment of chronic obstructive pulmonary disease (COPD). It is typically administered via nebulization and is prescribed for use twice daily to help control symptoms and improve airflow over a 24-hour period.

The mechanism of action allows for prolonged bronchodilation, which makes it effective in managing respiratory symptoms throughout the day when dosed as recommended. A twice-daily frequency maximizes the therapeutic effects while minimizing potential side effects associated with overuse.

In contrast, dosing once daily would not provide the necessary cover to manage persistent COPD symptoms effectively. Three or four times daily dosing is generally not utilized for long-acting agents like Brovana, as this may lead to increased side effects and patient non-compliance due to the burden of frequent administration.